News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1โ€“36
Matches
88
Sources here
25
Companies here
3
Search results Stored financial headlines

Active search

88 matching headlines

Ticker or company: COCHMain company stories
Clear
Latest

Investing.com Canada Analyst action

Lake Street initiates Envoy Medical stock at buy on cochlear device

Lake Street has initiated coverage on Envoy Medical Inc. (NASDAQ:COCH) with a Buy rating and a $2.50 price target, citing the company's fully implantable Acclaim cochlear implant which targets a significant market. The firm anticipates regulatory approval in late 2027 or early 2028, with key catalysts expected to drive share price appreciation. Despite the positive outlook, InvestingPro Tips โ€ฆ

Main company ๐Ÿ‡บ๐Ÿ‡ธ United States
Read at Investing.com Canada
Sharemaestro market context Trend signal active 52 weeks -23.4% COCH stored weekly price path from 10 Oct 2025 to 2 Oct 2026
Just inNext headlines
Simply Wall St Market update Main company ๐Ÿ‡ฆ๐Ÿ‡บ Australia

Cochlear And 2 Other Australian Healthcare Stocks To Own

Australian inflation accelerated to 4% in August, and interest rates now sit at a 15 year high of 4.6%. That mix is putting cost pressure on households while lifting the appeal of resilient sectors. Healthcare often holds up when budgets tighten because treatment is โ€ฆ

COH main company
Sharemaestro market context Price below Trend Line 52 weeks -55.3% COH stored weekly price path from 10 Oct 2025 to 2 Oct 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

finance.yahoo.com Market update Main company ๐Ÿ‡ฆ๐Ÿ‡บ Australia

Cochlear Reaches More Than 1 Million Hours of Patient Experience Across Its Fully Implantable Hearing Technology Research Program

Global clinical studies advance Cochlear's fully implantable hearing technology US, European and Australian pivotal trial recruitment completed, and more than 100 people implanted across the full research program Program reflects Cochlear's evidence-led approach to developing breakthrough technology focused on all-day hearing and implant battery โ€ฆ

COH main company
Sharemaestro market context Price below Trend Line 52 weeks -55.3% COH stored weekly price path from 10 Oct 2025 to 2 Oct 2026
TMX Newsfile Market update Main company ๐Ÿ‡บ๐Ÿ‡ธ United States

Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio

Envoy Medical Inc. has announced the grant of two new international patents in Canada and Hong Kong, expanding its global intellectual property portfolio to 97 patents. These patents cover technology related to integrated implantable cochlear systems and methods for compensating variability in middle ear โ€ฆ

COCH main company
Sharemaestro market context Trend signal active 52 weeks -23.4% COCH stored weekly price path from 10 Oct 2025 to 2 Oct 2026
GuruFocus.com Capital return Main company ๐Ÿ‡ฆ๐Ÿ‡บ Australia

Cochlear Ltd's Dividend Analysis

This article first appeared on GuruFocus. Evaluating the Sustainability of Cochlear Ltd's Upcoming Payout Cochlear Ltd (CHEOY) recently announced a total dividend of $0.47 per share, with the ex-dividend date set for 2026-09-22. This distribution includes a $0.47 per share cash dividend payable on โ€ฆ

COH main company
Sharemaestro market context Price below Trend Line 52 weeks -55.3% COH stored weekly price path from 10 Oct 2025 to 2 Oct 2026
TMX Newsfile Market update Main company ๐Ÿ‡บ๐Ÿ‡ธ United States

Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th

White Bear Lake, Minnesota--(Newsfile Corp. - September 2, 2026) - Envoy Medicalยฎ Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced that Brent Lucas, Envoy Medical's Chief Executive Officer, will present at the H.C. โ€ฆ

COCH main company
Sharemaestro market context Trend signal active 52 weeks -23.4% COCH stored weekly price path from 10 Oct 2025 to 2 Oct 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context